Current Funding Opportunities

To visit the NCI grant site, click here


Use your device's search function to find a specific disease or funding source. 


Breast 


Avon Breast Cancer Crusade 2017 Funding 
These research initiative funds translational research using clinical studies, human cell culture, epidemiologic, and other progressive approaches to understand the causes of breast cancer and develop new treatments.

Access to Care - Support Services Program

Supports programs providing services and education to women and men diagnosed with breast cancer, including nutrition support, counseling and referral programs, financial assistance programs, and information services. Application is by invitation only. To seek an invitation, please send a description of the proposed program to grants@avonbcc.org.



Colorectal

Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01) 
This Funding Opportunity Announcement (FOA) encourages the submission of applications that propose to advance research in cancer etiology and early detection biomarkers, utilizing the advantages of the unique biorepository resources of the NCI-sponsored Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) Screening Trial. The PLCO Biorepository offers high-quality, prospectively collected, serial pre-diagnostic blood samples from the PLCO screened arm participants, and a onetime collection of buccal cells from the control arm participants. Available data associated with the biospecimens includes demographic, diet, lifestyle, smoking, screening results, and clinical data. This FOA supports a wide range of cancer research including, but not limited to, biochemical and genetic analyses of cancer risk, as well as discovery and validation of early detection biomarkers. The proposed research project must involve use of PLCO biospecimens; additionally, it should also take advantage of the unique characteristics of the PLCO biospecimens. Research projects that do not involve the use of PLCO biospecimens will not be supported under this FOA.  
 
Application Due Date: Application Receipt/Submission Date(s): February 15, 2018; August 15, 2018, by 5:00 PM local time of applicant organization.
 

Lung 


A Breath of Hope Lung Foundation
A Breath of Hope Lung Foundation is proud to announce the $150,000 Tona Vives Research Award. Despite the dismal lung cancer mortality rate (only 17.8% of those diagnosed with lung cancer survive past five years - 160,000 Americans, both smokers and nonsmokers, die of lung cancer each year), basic research in lung cancer has not received the funding it needs to make significant gains in reducing the mortality rate of lung cancer. A Breath of Hope Lung Foundation (ABOHLF) is a young, growing nonprofit that intends to support creative researchers as they pursue bold research that could result in prolonged or saved lives and large contributions to science. Focused on the topic of understanding lung cancer in women, A Breath of Hope Lung Foundation is now accepting applications.

To confirm your eligibility to apply for this funding and receive the online application, please complete the online form.

Application Due Date: February 1, 2018 

Learn More>>


Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01) 
This Funding Opportunity Announcement (FOA) encourages the submission of applications that propose to advance research in cancer etiology and early detection biomarkers, utilizing the advantages of the unique biorepository resources of the NCI-sponsored Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) Screening Trial. The PLCO Biorepository offers high-quality, prospectively collected, serial pre-diagnostic blood samples from the PLCO screened arm participants, and a onetime collection of buccal cells from the control arm participants. Available data associated with the biospecimens includes demographic, diet, lifestyle, smoking, screening results, and clinical data. This FOA supports a wide range of cancer research including, but not limited to, biochemical and genetic analyses of cancer risk, as well as discovery and validation of early detection biomarkers. The proposed research project must involve use of PLCO biospecimens; additionally, it should also take advantage of the unique characteristics of the PLCO biospecimens. Research projects that do not involve the use of PLCO biospecimens will not be supported under this FOA.  
 
Application Due Date: Application Receipt/Submission Date(s): February 15, 2018; August 15, 2018, by 5:00 PM local time of applicant organization.

Ovarian

Department of Defense Ovarian Cancer Research Program Funding Opportunities

FY17 OCRP Program Announcements and General Application Instructions for the following award mechanisms are anticipated to be posted on Grants.gov in February 2017.  Pre-application and application deadlines will be available when the Program Announcements are released. 

Clinical Development Award
Must be an independent investigator at or above the level of Assistant Professor (or equivalent)

Investigator-Initiated Research Award
Must be an independent investigator at or above the level of Assistant Professor (or equivalent)

Ovarian Cancer Academy Award – Early-Career Investigator
Must be within 3 years of his/her last postdoctoral research position (Ph.D) or clinical fellowship (M.D.), or equivalent as of the full application submission deadline.  A letter attesting to eligibility is required.

Pilot Award
Established Investigator:  Independent investigator for whom it has been more than 3 years since his/her last postdoctoral research position (Ph.D) or clinical fellowship (M.D.), or equivalent; or
Early-Career Investigator:  Investigators must meet one of the following criteria by the application submission date: Must be within 3 years of his/her last postdoctoral research position (Ph.D) or clinical fellowship (M.D.) OR In a postdoctoral research position (Ph.D), or clinical fellowship (M.D.), or equivalent.  

Applications must be submitted through the federal government’s single-entry portal, Grants.gov.  Submission deadlines are not available until the Program Announcements are released.  


Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01) 
This Funding Opportunity Announcement (FOA) encourages the submission of applications that propose to advance research in cancer etiology and early detection biomarkers, utilizing the advantages of the unique biorepository resources of the NCI-sponsored Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) Screening Trial. The PLCO Biorepository offers high-quality, prospectively collected, serial pre-diagnostic blood samples from the PLCO screened arm participants, and a onetime collection of buccal cells from the control arm participants. Available data associated with the biospecimens includes demographic, diet, lifestyle, smoking, screening results, and clinical data. This FOA supports a wide range of cancer research including, but not limited to, biochemical and genetic analyses of cancer risk, as well as discovery and validation of early detection biomarkers. The proposed research project must involve use of PLCO biospecimens; additionally, it should also take advantage of the unique characteristics of the PLCO biospecimens. Research projects that do not involve the use of PLCO biospecimens will not be supported under this FOA.  
 
Application Due Date: Application Receipt/Submission Date(s): February 15, 2018; August 15, 2018, by 5:00 PM local time of applicant organization.
 

Pancreatic


2018 Translational Research Grant 
Supports independent investigators conducting high priority pancreatic cancer research that is poised for important translational next steps with a $500,000 grant over two years. Proposed research should aim to identify novel targets and approaches to the treatment of pancreatic cancer or understand and circumvent treatment resistance. 

Application Deadline: January 15, 2018 

Learn More>> 


The Pancreatic Cancer Detection Consortium (U01)
This Funding Opportunity Announcement (FOA) invites applications from multi-disciplinary teams of researchers and clinicians to establish the Pancreatic Cancer Detection Consortium (PCDC) to conduct research to improve the detection of early stage pancreatic ductal adenocarcinoma (PDAC) and characterization of its precursor lesions.

Application Due Date: April 6, 2018

Learn More>>

Lung 


A Breath of Hope Lung Foundation

A Breath of Hope Lung Foundation is proud to announce the $150,000 Tona Vives Research Award. Despite the dismal lung cancer mortality rate (only 17.8% of those diagnosed with lung cancer survive past five years - 160,000 Americans, both smokers and nonsmokers, die of lung cancer each year), basic research in lung cancer has not received the funding it needs to make significant gains in reducing the mortality rate of lung cancer. A Breath of Hope Lung Foundation (ABOHLF) is a young, growing nonprofit that intends to support creative researchers as they pursue bold research that could result in prolonged or saved lives and large contributions to science. Focused on the topic of understanding lung cancer in women, A Breath of Hope Lung Foundation is now accepting applications. 

To confirm your eligibility to apply for this funding and receive the online application, please complete the online form.


Application Due Date: February 1, 2018 

Learn More>>

AVON 

Avon Breast Cancer Crusade 2017 Funding 

These research initiative funds translational research using clinical studies, human cell culture, epidemiologic, and other progressive approaches to understand the causes of breast cancer and develop new treatments.


Access to Care - Support Services Program

Supports programs providing services and education to women and men diagnosed with breast cancer, including nutrition support, counseling and referral programs, financial assistance programs, and information services. Application is by invitation only. To seek an invitation, please send a description of the proposed program to grants@avonbcc.org.

The Howard Hughes Medical Institute

The Hanna H. Gray Fellows Program Competition

The goal of the Hanna H. Gray Fellows Program is to recruit and retain individuals who are from gender, racial, ethnic, and other groups underrepresented in the life sciences, including those from disadvantaged backgrounds, early in their careers. The Hanna H. Gray Fellows Program supports early-career life scientists in academic labs across the U.S. The 2018 competition is now open.

Application Deadline: January 10, 2018

NIH/NCI


Academic-Industrial Partnerships for Translation of Technologies for Cancer Diagnosis and Treatment (R01) 
This Funding Opportunity Announcement (FOA) encourages applications from research partnerships formed by academic and industrial investigators, to accelerate the translation of technologies, methods, assays or devices, and/or systems for preclinical or clinical molecular diagnosis or in vitro imaging that are designed to solve a targeted cancer problem.

Application Due Date: January 8, 2018

Learn More>>


Minority Patient-Derived Xenograft (PDX) Development and Trial Centers (M-PDTCs) (U54)   

The main goals for this initiative include: a) Development of racially/ethnically diverse PDX models; b) Development of methods for preclinical testing of single agents and drug combinations; and c) Conducting response studies of PDX models, primarily from racially/ethnically diverse populations, to develop novel therapeutic strategies.


Application Due Date: January 18, 2018

Learn More>>



Feasibility and Planning Studies for Development of Specialized Programs of Research Excellence (SPOREs) to Investigate Cancer Health Disparities (P20)  

The goals for this FOA include the development of translational research programs focused upon investigating cancer health disparities. The P20 grants will support feasibility and planning activities to build cancer health disparities research programs, with the expectation that the research programs will become competitive for a full Specialized Programs of Research Excellence (SPORE).

Application Due Date: January 18, 2018  




Feasibility Studies to Build Collaborative Partnerships in Cancer Research (P20) 
Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) invites P20 planning grant applications for  developing collaborative partnership between institutions serving underserved health disparity populations and underrepresented students (ISUPS) and NCI- designated Cancer Centers. 

Application Due Date: January 29, 2018 

Learn More>>

Pancreatic Cancer Action Network


2018 Translational Research Grant
Supports independent investigators conducting high priority pancreatic cancer research that is poised for important translational next steps with a $500,000 grant over two years. Proposed research should aim to identify novel targets and approaches to the treatment of pancreatic cancer or understand and circumvent treatment resistance.

Application Deadline: January 15, 2018

Learn More>>


The Pancreatic Cancer Detection Consortium (U01)  
This Funding Opportunity Announcement (FOA) invites applications from multi-disciplinary teams of researchers and clinicians to establish the Pancreatic Cancer Detection Consortium (PCDC) to conduct research to improve the detection of early stage pancreatic ductal adenocarcinoma (PDAC) and characterization of its precursor lesions. 

Application Due Date: April 6, 2018 

Learn More>>


The Yale Cancer Center Internal Grant Program aims to provide funds for innovative, high quality start-up cancer research programs and provide new investigators with experience and guidance in the grant-writing process. 

The criteria for funding is high quality, innovative cancer research with a likelihood to result in NIH-funded cancer research and encourage collaborations within YCC. Grant competitions will be announced in DirectConnect and will undergo an anonymous NIH-style peer review with written reviews provided to applicants. 

Click to see all the Internal Grants from 2012-2016.


Lion Heart Grants
  • Funding amount based on fundraising annually done by Lion Hearts
  • For Yale Cancer Center members only 
  • To support breast cancer research
  • Committee of Yale Cancer Center members and Lion Heart members review and select grant recipients
  • Administered by Brigid Killelea


SPORE in Lung Cancer Program Awards

Learn More>>

LungSPORE@yale.edu     



V Foundation Pediatric Cancer Grants
  • ONE NOMINEE TO APPLY FOR EITHER THE V SCHOLAR OR TRANSLATIONAL AWARD
  • The nominee must be nominated by their Cancer Center Director if the research institution is a cancer center. If the research institution is not a cancer center, then the department chair or other senior research administrative official who is responsible for the internal nominee 
  • Applicant must be employed at a non-profit research institution 
  • Administered by Gary Kupfer  

American Cancer Society Institutional Research Grants
  • $30,000 for one year
  • For assistant professors only
  • Prior national research grant disqualifies
  • Four awards per year
  • Usually reviewed in December
  • Administered by Joann Sweasy

Rausch Foun dation Grants in Community Health
  • $30,000-$50,000 for one year
  • Population science focus
  • Priority to projects with impact to New Haven
  • Administered by Melinda Irwin 

YCC Pilot Grants
  • $50,000 for one year
  • All YCC members eligible to apply
  • Specific project proposed by individual investigator
  • Seven or eight awards per year, distributed among all seven research programs
  • Usually reviewed in Spring
  • Administered by Joann Sweasy
  • For more information, please contact Jan Zulkeski

T-TARE Award
  • Up to $200,000 for one year
  • For teams of investigators
  • Research with a translational focus
  • Major goal is to generate data and evidence of collaboration for multi-investigator grant application
  • Administered by Roy Herbst

Yale Discovery Fund Grants 

  • $450,000 to be spent over three years
  • High-risk/high-reward cancer research
  • Multidisciplinary collaborative research
  • Hope to fund 3 – 4 each year
  • Administered by Dan DiMaio

Leslie Warner Postdoctoral Fellowship
  • ~$42,000 for one year
  • Fellows working in YCC member laboratories eligible to apply
  • Must be in first year of fellowship
  • Four awards every other year
  • Usually reviewed in fall
  • Review organized by Karen Anderson